CN Patent

CN114588107A — 一种布洛芬赖氨酸盐注射液及其制备方法

Assigned to Hebei Yipin Biomedical Co ltd · Expires 2022-06-07 · 4y expired

What this patent protects

本发明提供一种布洛芬赖氨酸盐注射液及其制备方法，属于药物制剂技术领域。该注射液含有布洛芬赖氨酸盐、β‑环糊精和pH调节剂。该注射液具有易储存、运输、稳定性好、不易变质，更方便临床应用的特点。

USPTO Abstract

本发明提供一种布洛芬赖氨酸盐注射液及其制备方法，属于药物制剂技术领域。该注射液含有布洛芬赖氨酸盐、β‑环糊精和pH调节剂。该注射液具有易储存、运输、稳定性好、不易变质，更方便临床应用的特点。

Drugs covered by this patent

cysteine-hydrochloride (CYSTEINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN114588107A
Jurisdiction: CN
Classification: —
Expires: 2022-06-07
Drug substance claim: No
Drug product claim: No
Assignee: Hebei Yipin Biomedical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.